| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Global distribution of Panton-Valentine leukocidin--positive methicillin-resistant Staphylococcus aureus, 2006.
|
Emerg Infect Dis
|
2007
|
3.98
|
|
2
|
Tackling antibiotic resistance.
|
Nat Rev Microbiol
|
2011
|
3.95
|
|
3
|
Plasmid-mediated high-level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation.
|
Antimicrob Agents Chemother
|
2003
|
3.22
|
|
4
|
Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system.
|
Antimicrob Agents Chemother
|
2004
|
2.89
|
|
5
|
Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli.
|
Antimicrob Agents Chemother
|
2007
|
2.67
|
|
6
|
Modes and modulations of antibiotic resistance gene expression.
|
Clin Microbiol Rev
|
2007
|
2.66
|
|
7
|
ColE1-like plasmid pIP843 of Klebsiella pneumoniae encoding extended-spectrum beta-lactamase CTX-M-17.
|
Antimicrob Agents Chemother
|
2002
|
2.21
|
|
8
|
Resistance to macrolides and related antibiotics in Streptococcus pneumoniae.
|
Antimicrob Agents Chemother
|
2002
|
2.17
|
|
9
|
Detection of the van alphabet and identification of enterococci and staphylococci at the species level by multiplex PCR.
|
J Clin Microbiol
|
2004
|
2.07
|
|
10
|
AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii.
|
Antimicrob Agents Chemother
|
2007
|
2.04
|
|
11
|
Resistance of Yersinia pestis to antimicrobial agents.
|
Antimicrob Agents Chemother
|
2006
|
1.97
|
|
12
|
Treatment of health-care-associated infections caused by Gram-negative bacteria: a consensus statement.
|
Lancet Infect Dis
|
2008
|
1.96
|
|
13
|
Distribution of extended-spectrum beta-lactamases in clinical isolates of Enterobacteriaceae in Vietnam.
|
Antimicrob Agents Chemother
|
2002
|
1.94
|
|
14
|
Efflux-mediated antibiotic resistance in Acinetobacter spp.
|
Antimicrob Agents Chemother
|
2010
|
1.89
|
|
15
|
armA and aminoglycoside resistance in Escherichia coli.
|
Emerg Infect Dis
|
2005
|
1.70
|
|
16
|
VanA-type vancomycin-resistant Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2009
|
1.64
|
|
17
|
The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.
|
Mol Microbiol
|
2003
|
1.64
|
|
18
|
Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii.
|
Antimicrob Agents Chemother
|
2010
|
1.58
|
|
19
|
Glycopeptide antibiotics: from conventional molecules to new derivatives.
|
Drugs
|
2004
|
1.56
|
|
20
|
Revised nomenclature for transposable genetic elements.
|
Plasmid
|
2008
|
1.50
|
|
21
|
RmtF, a new member of the aminoglycoside resistance 16S rRNA N7 G1405 methyltransferase family.
|
Antimicrob Agents Chemother
|
2012
|
1.49
|
|
22
|
Aminoglycoside resistance by ArmA-mediated ribosomal 16S methylation in human bacterial pathogens.
|
J Mol Biol
|
2006
|
1.48
|
|
23
|
Sequence of conjugative plasmid pIP1206 mediating resistance to aminoglycosides by 16S rRNA methylation and to hydrophilic fluoroquinolones by efflux.
|
Antimicrob Agents Chemother
|
2008
|
1.44
|
|
24
|
Inducible expression eliminates the fitness cost of vancomycin resistance in enterococci.
|
Proc Natl Acad Sci U S A
|
2010
|
1.44
|
|
25
|
European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates.
|
J Antimicrob Chemother
|
2003
|
1.40
|
|
26
|
Fitness cost of VanA-type vancomycin resistance in methicillin-resistant Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2009
|
1.38
|
|
27
|
Screening and quantification of the expression of antibiotic resistance genes in Acinetobacter baumannii with a microarray.
|
Antimicrob Agents Chemother
|
2009
|
1.36
|
|
28
|
GES-11, a novel integron-associated GES variant in Acinetobacter baumannii.
|
Antimicrob Agents Chemother
|
2009
|
1.36
|
|
29
|
Emergence of colistin-resistance in extremely drug-resistant Acinetobacter baumannii containing a novel pmrCAB operon during colistin therapy of wound infections.
|
J Infect Dis
|
2013
|
1.32
|
|
30
|
A six amino acid deletion, partially overlapping the VanSB G2 ATP-binding motif, leads to constitutive glycopeptide resistance in VanB-type Enterococcus faecium.
|
Mol Microbiol
|
2003
|
1.24
|
|
31
|
Integron-associated antibiotic resistance and phylogenetic grouping of Escherichia coli isolates from healthy subjects free of recent antibiotic exposure.
|
Antimicrob Agents Chemother
|
2005
|
1.22
|
|
32
|
VanD-type vancomycin-resistant Enterococcus faecium and Enterococcus faecalis.
|
Antimicrob Agents Chemother
|
2004
|
1.22
|
|
33
|
Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes.
|
Antimicrob Agents Chemother
|
2003
|
1.22
|
|
34
|
RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations.
|
Antimicrob Agents Chemother
|
2013
|
1.20
|
|
35
|
D-Ala-d-Ser VanN-type transferable vancomycin resistance in Enterococcus faecium.
|
Antimicrob Agents Chemother
|
2011
|
1.20
|
|
36
|
Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.
|
Antimicrob Agents Chemother
|
2005
|
1.19
|
|
37
|
Structural bases for 16 S rRNA methylation catalyzed by ArmA and RmtB methyltransferases.
|
J Mol Biol
|
2009
|
1.17
|
|
38
|
Synergism between beta-lactams and glycopeptides against VanA-type methicillin-resistant Staphylococcus aureus and heterologous expression of the vanA operon.
|
Antimicrob Agents Chemother
|
2006
|
1.17
|
|
39
|
rpoB mutation conferring rifampin resistance in Streptococcus pyogenes.
|
Antimicrob Agents Chemother
|
2002
|
1.15
|
|
40
|
Acquisition of multidrug resistance transposon Tn6061 and IS6100-mediated large chromosomal inversions in Pseudomonas aeruginosa clinical isolates.
|
Microbiology
|
2010
|
1.12
|
|
41
|
Bacterial and host factors implicated in nasal carriage of methicillin-resistant Staphylococcus aureus in mice.
|
Infect Immun
|
2005
|
1.10
|
|
42
|
VanD-type vancomycin-resistant Enterococcus faecium 10/96A.
|
Antimicrob Agents Chemother
|
2003
|
1.09
|
|
43
|
Heterologous expression of the enterococcal vanA operon in methicillin-resistant Staphylococcus aureus.
|
Antimicrob Agents Chemother
|
2004
|
1.08
|
|
44
|
Organic and conventional fruits and vegetables contain equivalent counts of Gram-negative bacteria expressing resistance to antibacterial agents.
|
Environ Microbiol
|
2009
|
1.08
|
|
45
|
Expert systems in clinical microbiology.
|
Clin Microbiol Rev
|
2011
|
1.07
|
|
46
|
The battle against emerging antibiotic resistance: should fluoroquinolones be used to treat children?
|
Clin Infect Dis
|
2002
|
1.04
|
|
47
|
Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator.
|
Antimicrob Agents Chemother
|
2012
|
1.04
|
|
48
|
An extended PCR-RFLP assay for detection of parC, parE and gyrA mutations in fluoroquinolone-resistant Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2004
|
1.03
|
|
49
|
Development of ertapenem resistance in a patient with mediastinitis caused by Klebsiella pneumoniae producing an extended-spectrum beta-lactamase.
|
J Med Microbiol
|
2010
|
1.01
|
|
50
|
vanE gene cluster of vancomycin-resistant Enterococcus faecalis BM4405.
|
J Bacteriol
|
2002
|
1.00
|
|
51
|
Wild-type intracellular bacteria deliver DNA into mammalian cells.
|
Cell Microbiol
|
2002
|
0.97
|
|
52
|
Fluoroquinolones induce the expression of patA and patB, which encode ABC efflux pumps in Streptococcus pneumoniae.
|
J Antimicrob Chemother
|
2010
|
0.95
|
|
53
|
Invasive Streptococcus pneumoniae in France: antimicrobial resistance, serotype, and molecular epidemiology findings from a monthly national study in 2000 to 2002.
|
Antimicrob Agents Chemother
|
2004
|
0.95
|
|
54
|
Binding sites of VanRB and sigma70 RNA polymerase in the vanB vancomycin resistance operon of Enterococcus faecium BM4524.
|
Mol Microbiol
|
2005
|
0.95
|
|
55
|
parC mutation conferring ciprofloxacin resistance in Streptococcus pyogenes BM4513.
|
Antimicrob Agents Chemother
|
2002
|
0.95
|
|
56
|
Antimicrobial resistance of Listeria monocytogenes isolates from food and the environment in France over a 10-year period.
|
Appl Environ Microbiol
|
2011
|
0.94
|
|
57
|
An emptying quiver: antimicrobial drugs and resistance.
|
Emerg Infect Dis
|
2005
|
0.93
|
|
58
|
Amplification of aminoglycoside resistance gene aphA1 in Acinetobacter baumannii results in tobramycin therapy failure.
|
MBio
|
2014
|
0.93
|
|
59
|
Plasmid-mediated quinolone resistance in expanded spectrum beta lactamase producing enterobacteriaceae in Morocco.
|
J Infect Dev Ctries
|
2010
|
0.93
|
|
60
|
Comparison of four methods, including semi-automated rep-PCR, for the typing of vancomycin-resistant Enterococcus faecium.
|
J Microbiol Methods
|
2010
|
0.92
|
|
61
|
Identification of 50 class D β-lactamases and 65 Acinetobacter-derived cephalosporinases in Acinetobacter spp.
|
Antimicrob Agents Chemother
|
2013
|
0.92
|
|
62
|
Aminoglycoside resistance gene ant(4')-IIb of Pseudomonas aeruginosa BM4492, a clinical isolate from Bulgaria.
|
Antimicrob Agents Chemother
|
2003
|
0.92
|
|
63
|
Definition and determination of in vitro antibiotic susceptibility breakpoints for bacteria.
|
Clin Microbiol Infect
|
1996
|
0.91
|
|
64
|
VanA-mediated high level glycopeptide resistance in MRSA.
|
Lancet Infect Dis
|
2003
|
0.91
|
|
65
|
Structural basis of Synercid (quinupristin-dalfopristin) resistance in Gram-positive bacterial pathogens.
|
J Biol Chem
|
2003
|
0.90
|
|
66
|
Acquired gentamicin resistance by permeability impairment in Enterococcus faecalis.
|
Antimicrob Agents Chemother
|
2006
|
0.90
|
|
67
|
VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth.
|
Antimicrob Agents Chemother
|
2009
|
0.89
|
|
68
|
Glycopeptide resistance vanA operons in Paenibacillus strains isolated from soil.
|
Antimicrob Agents Chemother
|
2005
|
0.89
|
|
69
|
The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance.
|
Mol Microbiol
|
2013
|
0.88
|
|
70
|
RAHN-2, a chromosomal extended-spectrum class A beta-lactamase from Rahnella aquatilis.
|
J Antimicrob Chemother
|
2010
|
0.87
|
|
71
|
Resistance phenotypes conferred by macrolide phosphotransferases.
|
FEMS Microbiol Lett
|
2007
|
0.87
|
|
72
|
Chromosomal aadD2 encodes an aminoglycoside nucleotidyltransferase in Bacillus clausii.
|
Antimicrob Agents Chemother
|
2003
|
0.85
|
|
73
|
Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.
|
Antimicrob Agents Chemother
|
2008
|
0.85
|
|
74
|
Transcriptional analysis of the vanC cluster from Enterococcus gallinarum strains with constitutive and inducible vancomycin resistance.
|
Antimicrob Agents Chemother
|
2005
|
0.85
|
|
75
|
Ceftazidime-hydrolysing β-lactamase OXA-145 with impaired hydrolysis of penicillins in Pseudomonas aeruginosa.
|
J Antimicrob Chemother
|
2011
|
0.84
|
|
76
|
Emergence of carbapenem-resistant Hafnia: the fall of the last soldier.
|
Clin Infect Dis
|
2010
|
0.84
|
|
77
|
Eukaryotic promoters can direct protein synthesis in Gram-negative bacteria.
|
J Mol Microbiol Biotechnol
|
2003
|
0.84
|
|
78
|
TEM-103/IRT-28 beta-lactamase, a new TEM variant produced by Escherichia coli BM4511.
|
Antimicrob Agents Chemother
|
2002
|
0.83
|
|
79
|
Structural basis for the evolution of vancomycin resistance D,D-peptidases.
|
Proc Natl Acad Sci U S A
|
2014
|
0.83
|
|
80
|
Structural and functional characterization of VanG D-Ala:D-Ser ligase associated with vancomycin resistance in Enterococcus faecalis.
|
J Biol Chem
|
2012
|
0.83
|
|
81
|
Functional motions modulating VanA ligand binding unraveled by self-organizing maps.
|
J Chem Inf Model
|
2014
|
0.82
|
|
82
|
Genetic and biochemical characterization of OXA-63, a new class D beta-lactamase from Brachyspira pilosicoli BM4442.
|
Antimicrob Agents Chemother
|
2008
|
0.81
|
|
83
|
VanB-type Enterococcus faecium clinical isolate successively inducibly resistant to, dependent on, and constitutively resistant to vancomycin.
|
Antimicrob Agents Chemother
|
2009
|
0.81
|
|
84
|
Molecular basis of vancomycin dependence in VanA-type Staphylococcus aureus VRSA-9.
|
J Bacteriol
|
2010
|
0.80
|
|
85
|
Expression of glycopeptide-resistance gene in response to vancomycin and teicoplanin in the cardiac vegetations of rabbits infected with VanB-type Enterococcus faecalis.
|
J Infect Dis
|
2003
|
0.80
|
|
86
|
Aminoglycoside resistance 16S rRNA methyltransferases block endogenous methylation, affect translation efficiency and fitness of the host.
|
RNA
|
2014
|
0.80
|
|
87
|
Intrinsic resistance to aminoglycosides in Enterococcus faecium is conferred by the 16S rRNA m5C1404-specific methyltransferase EfmM.
|
RNA
|
2010
|
0.80
|
|
88
|
Crystallization and preliminary X-ray analysis of a D-Ala:D-Ser ligase associated with VanG-type vancomycin resistance.
|
Acta Crystallogr Sect F Struct Biol Cryst Commun
|
2009
|
0.79
|
|
89
|
Emergence of an Enterobacter hormaechei strain with reduced susceptibility to tigecycline under tigecycline therapy.
|
Antimicrob Agents Chemother
|
2009
|
0.79
|
|
90
|
VanE-type vancomycin-resistant Enterococcus faecalis clinical isolates from Australia.
|
Antimicrob Agents Chemother
|
2004
|
0.78
|
|
91
|
Highly rifampin-resistant Listeria monocytogenes isolated from a patient with prosthetic bone infection.
|
Antimicrob Agents Chemother
|
2014
|
0.78
|
|
92
|
Epidemiology and mechanisms of resistance among respiratory tract pathogens.
|
Clin Microbiol Infect
|
1998
|
0.77
|
|
93
|
Emergence and dissemination of a new mechanism of resistance to aminoglycosides in Gram-negative bacteria: 16S rRNA methylation.
|
Euro Surveill
|
2005
|
0.76
|
|
94
|
Influence of VanD type resistance on activities of glycopeptides in vitro and in experimental endocarditis due to Enterococcus faecium.
|
Antimicrob Agents Chemother
|
2003
|
0.75
|
|
95
|
Silencing of glycopeptide resistance in Enterococcus faecalis BM4405 by novobiocin.
|
Antimicrob Agents Chemother
|
2005
|
0.75
|
|
96
|
Genetic and biochemical characterization of CAD-1, a chromosomally encoded new class A penicillinase from Carnobacterium divergens.
|
Antimicrob Agents Chemother
|
2007
|
0.75
|
|
97
|
Staphylococcus aureus VRSA-11B is a constitutive vancomycin-resistant mutant of vancomycin-dependent VRSA-11A.
|
Antimicrob Agents Chemother
|
2012
|
0.75
|
|
98
|
Any impact of bacterial resistance on antibiotic use in the community?
|
Int J Med Microbiol
|
2002
|
0.75
|
|
99
|
Evolution of antimicrobial resistance: impact on antibiotic use.
|
Semin Respir Crit Care Med
|
2002
|
0.75
|